09.04.26 -- What Goes Into Restarting A Shelved Orphan Drug Candidate?

Implementing the EU GMP Annex 1 requires a holistic, evolutionary Contamination Control Strategy built on standardization, data analytics, and continuous improvement for a zero-defect mindset.

Ensure product quality and patient safety by examining the FDA's draft guideline on Computer Software Assurance that emphasizes a risk-based approach to streamline software validation.

Explore how Annex 1 applies to low bioburden DS manufacturing and promotes a risk-based approach to contamination control that balances regulatory compliance with operational efficiency.

Navigate the challenging path from concept to clinical reality by partnering with an experienced CDMO that can provide the expertise needed to move your therapeutic forward.

Stay ahead of FDA QMSR, EU GMP, and AI regulations by adopting continuous audit readiness, ALCOA++ data integrity, and closed-loop workflows for global compliance.

Establish robust visual inspection rotations by separating planned dates from compliance expirations and using standardized templates to prevent scheduling bottlenecks.

Accurate cleanroom particle monitoring requires precise isokinetic sampling. Understand how to maintain sampling accuracy and meet regulatory airflow requirements for your facility.

Gain insights into comparative performance, workflow flexibility, and practical considerations for implementing a new weak anion exchange hydrophobic resin and a strong anion exchange resin.

Match fluorochromes with lasers for precise flow cytometry. Learn brightness levels, antigen pairing recommendations, and tips to reduce nonspecific binding for optimal panel design and reliable results.

Leverage process analytical technologies (PAT) to gain real-time insight into product quality, strengthen control strategies, and build more efficient, scalable manufacturing processes for future success.

Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

Discover how natural language inputs transform into reliable analytics to help teams iterate quickly and move from concept to production‑ready dashboards without coding barriers.

Traditional models often fall short in women’s health research. Read about how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

Improve 3D spheroid consistency by optimizing cell selection, seeding density, and plate geometry. See how practical workflows and comparative data help reduce variability and establish reliability.

Data-driven virus clearance improves risk assessment, process insight, and study design. Delve into how QbD cuts late-stage risk while strengthening regulatory confidence and viral safety.

While biological indicators have long been the industry standard for evaluating bio-decontamination cycles, faster, cheaper, and quantifiable contamination detection technologies are emerging.

Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.

Complex biologics development increasingly relies on adaptive, knowledge-driven strategies combining platform methods and more to accelerate IND readiness.